Lucintel’s latest market report analyzed that immunohematology provides attractive opportunities in pretransfusion testing, ABO and Rh typing, antibody detection, cross matching, investigation of immune hemolysis, perinatal testing, blood group phenotyping/genotyping, and leucocyte & platelet serology. The immunohematology market is expected to grow at a CAGR of 4%-6%. In this market, immunohematology reagents are the largest segment by product, whereas hospitals are largest by end use.
Download Brochure of this report by clicking on https://www.lucintel.com/immunohematology-market.aspx
Based on product, the immunohematology market is segmented into immunohematology reagents, immunohematology analyzers, automated analyzers, and semi-automated analyzers / non-automated analyzers. The immunohematology reagents segment accounted for the largest share of the market in 2020 due to growing number of blood banks and increased use of reagents in immunohematology tests.
Browse in-depth TOC on “Immunohematology Market”
XX – Tables
XX – Figures
The immunohematology market is marked by the presence of several big and small players. Some of the prominent players offering immunohematology include Bio-Rad Laboratories, Grifols, Ortho Clinical Diagnostics, IMMUCOR, Abbott Laboratories, Beckman Coulter, Thermo Fisher Scientific, Becton, Dickinson and Company, Merck, and Siemens Healthineers.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link firstname.lastname@example.org.
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.